Skip to main content
Register
Medicine Matters Rheumatology
TOOLBAR 1 2 3 4
SEARCH
MENU 1 2 3 4
Close search form
main-content
Top
Print
​
print
​
share

13-11-2019 | Rheumatoid arthritis | Video | Article

Researcher comment: The NORD-STAR trial

Merete Hetland discusses the NORD-STAR trial findings comparing remission rates after active conventional versus biologic treatment in patients with early rheumatoid arthritis (3:52).  

Receive weekly updates on the rheumatology news that matters to you

Register for the e-alert!


Transcript

Back to the ACR/ARP 2019 conference hub

Related topics

Biologics rotated-square
Methotrexate rotated-square
Certolizumab pegol rotated-square
Abatacept rotated-square
Tocilizumab rotated-square
TNF inhibitors rotated-square
ACR/ARP 2019 rotated-square

Related content

13-11-2019 | Rheumatoid arthritis | ACR/ARP 2019 | News

Methotrexate plus glucocorticoids compare favorably with biologics in early RA

31-01-2019 | Rheumatoid arthritis | Highlight | News

Effectiveness of tocilizumab, rituximab over other biologics demonstrated

10-01-2019 | Rheumatoid arthritis | News

Biologic combination therapy for RA may increase risk for side effects

05-11-2019 | Rheumatoid arthritis | Feature | Article

​​​​​​​Treatment tapering in RA: A 2019 update
Why, when, and how should treatment be tapered in people with rheumatoid arthritis?

Version: 20200213133195_0.609.0_b218e20